HIV service ambassador program for people who use drugs
Part of Infections clinical trials.
This trial trains people who use drugs to talk with friends in their social network about HIV testing and services. It aims to encourage more people to get tested and linked to care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have used drugs in the past month (for index participants) or past 3 months (for peer recruits).
- You have people in your social network who also use drugs.
- You are willing to talk to at least 2 friends about HIV testing and services.
- You speak English fluently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help sexually active young adults reduce stimulant use and risky sexual behavior. It involves online coaching sessions, and you can join from home if you have a private space and video chat access.
This study looks at how to better support young men living with or at risk for HIV while also addressing substance use. You'll work with a care team that helps you stay healthy and connected to services.
This study looks at using social connections to help people who inject drugs get HIV prevention and substance use support. The trial tests a program in Los Angeles that works with friends or peers to encourage PrEP (HIV prevention pills) and addiction treatment.
This study tests how well a program combining telemedicine (virtual doctor visits) and peer support can help prevent HIV among people who inject drugs. You'd get trained, attend weekly group sessions, and invite a friend or partner to also take part.
This study tests if a program that encourages positive activities (behavioral activation) can help people with HIV or on PrEP who also use substances improve their health. It focuses on those receiving long-acting injectable medications for HIV prevention or treatment.
This study works with syringe service programs to see if offering opt-out HIV and hepatitis C testing helps more people get screened and connected to care. It focuses on programs that do not already offer this testing and are in high-need areas.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.